Stay updated on ICT-107 Immunotherapy in GBM Clinical Trial

Sign up to get notified when there's something new on the ICT-107 Immunotherapy in GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ICT-107 Immunotherapy in GBM Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The clinical trial record for ICT-107 in glioblastoma is displayed, including study design, eligibility criteria, participating locations, outcome measures, and study dates. Previously, the page showed a 403 Forbidden error.
    Difference
    53%
    Check dated 2026-11-08T14:47:56.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:54:19.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide notice announces that NIH is transitioning from using “Artificial Intelligence” to “Super Intelligence” terminology. The clinical trial details remain unavailable on the page.
    Difference
    1%
    Check dated 2026-10-25T15:44:12.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T19:24:47.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer’s site revision label was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T19:20:01.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden error, with navigation elements visible but no study details. This suggests an access or server issue rather than an update to the study content.
    Difference
    17%
    Check dated 2026-09-20T19:35:54.000Z thumbnail image

Stay in the know with updates to ICT-107 Immunotherapy in GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ICT-107 Immunotherapy in GBM Clinical Trial page.